Evidence map›Paper›PMID 19883953›Full record

ArticleNeurobiology of aging2011

Tonic Premarin dose-dependently enhances memory, affects neurotrophin protein levels and alters gene expression in middle-aged rats.

Elizabeth Engler-Chiurazzi, Candy Tsang, Sean Nonnenmacher, Winnie S Liang, Jason J Corneveaux, Laszlo Prokai, Matthew J Huentelman, Heather A Bimonte-Nelson

Abstract read
In one paragraph

Article in Neurobiology of aging, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it, 73 citations in OpenAlex.

  1. Pooled it
  2. Differences in verbal memory performance in postmenopausal women receiving hormone therapy: 17β-estradiol versus conjugated equine estrogens.The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2011
    Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Menopause, hormone therapy and cognition: maximizing translation from preclinical research.Climacteric : the journal of the International Menopause Society · 2021
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Elizabeth Engler-ChiurazziDepartment of Psychology, Arizona State University, Tempe, AZ 85287, USA. Elizabeth.engler-chiurazzi@asu.edu
Candy Tsang
Sean Nonnenmacher
Winnie S Liang
Jason J Corneveaux
Laszlo Prokai
Matthew J Huentelman
Heather A Bimonte-Nelson
Arizona State University · USArizona Alzheimer’s ConsortiumTranslational Genomics Research Institute · USUniversity of North Texas Health Science Center · US

Funding

Variations in Hormone Therapy: Effects on Cognition and Markers of Brain AgingR01AG028084 · NIA · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI BIMONTE-NELSON, HEATHER ALLYSON · 2007 to 2022
$4.7M
NIA NIH HHS AG028084NIA NIH HHS R01 AG028084
6 · The paper itself

Abstract

Premarin™ is the most commonly prescribed estrogenic component of hormone therapy, given since 1942. The current study is the first examining cognitive effects of tonic Premarin treatment in an animal model. Middle-aged ovariectomized (Ovx) rats received vehicle or one of three doses of Premarin (12, 24 or 36μg daily). Rats were tested on a spatial working and reference memory maze battery. Both medium- and high-dose Premarin enhanced memory retention, while low-dose Premarin impaired learning and memory retention. Correlations with serum hormone levels showed that as the ratio of estrone:17β-estradiol increased, animals tended to show better working memory performance. Taken together with the dissociation of dose-specific estrogenic profiles, results suggest that higher levels of estrone, in the presence of 17β-estradiol concentrations higher than that of Ovx levels, may be beneficial for memory. Moreover, Premarin exerted dose and brain-region specific effects on BDNF and NGF protein levels, with most marked changes in cingulate and perirhinal cortices. Hippocampal gene expression profiling demonstrated significant Premarin-induced transcriptional changes in genes linked to plasticity and cognition. These findings indicate that Premarin can impact memory and the brain, and that dosing should be recognized as a clinically relevant factor possibly affecting the direction and efficacy of cognitive outcome.

Indexed as

AnimalsBrain-Derived Neurotrophic FactorCerebral CortexDose-Response Relationship, DrugEstrogensEstrogens, Conjugated (USP)FemaleGene ExpressionHippocampusMaze LearningMemoryNerve Growth FactorOvariectomyRatsRats, Inbred F344Space PerceptionBrain-Derived Neurotrophic FactorEstrogensEstrogens, Conjugated (USP)Nerve Growth Factor

Identifiers

PMID19883953
PMCPMC3016463
OpenAlexW2158520770

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.